Title of article :
18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth
Author/Authors :
Çayır, Derya Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey , Araz, Mine Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey
Abstract :
Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) is used in staging, restaging, and evaluation of therapy response in many cancers as well as differentiated thyroid carcinomas especially in non-iodine avid variants. Its potential in less frequent thyroid tumors like medullary, anaplastic thyroid cancers, thyroid lymphoma and metastatic tumors of the thyroid however, is not well established yet. The aim of this review is to provide an overview on the recent applications and indications of 18F-FDG PET/CT in these tumors and to focus on the controversies in the clinical setting.
Keywords :
18F-fluorodeoxyglucose , positron emission tomography , Thyroid cancer
Journal title :
Molecular Imaging and Radionuclide Therapy
